Immediate Impact
3 from Science/Nature 59 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
2025 Standout
Works of Denise Uyar being referenced
Phase 1 dose-escalation study of STRO-002, an antifolate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced, progressive platinum-resistant/refractory epithelial ovarian cancer (EOC).
2021
A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53 -mutant Ovarian Cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Denise Uyar | 241 | 222 | 133 | 249 | 40 | 643 | |
| Antonella Pietragalla | 262 | 203 | 147 | 257 | 35 | 664 | |
| Satoshi Tsunetoh | 239 | 227 | 182 | 277 | 32 | 699 | |
| Yasunori Hashiguchi | 226 | 187 | 85 | 233 | 36 | 535 | |
| Satoe Fujiwara | 222 | 198 | 161 | 274 | 36 | 656 | |
| Gaia Giannone | 328 | 192 | 99 | 251 | 32 | 708 | |
| Hye Sook Chon | 211 | 187 | 120 | 206 | 64 | 629 | |
| Won Duk Joo | 139 | 169 | 126 | 255 | 39 | 614 | |
| Sally Baron‐Hay | 365 | 200 | 131 | 231 | 44 | 734 | |
| Svend A. Engelholm | 260 | 199 | 96 | 177 | 37 | 687 | |
| J. M. G. Bonfrer | 203 | 182 | 55 | 256 | 25 | 663 |
All Works
Login with ORCID to disown or claim papers
Loading papers...